comparemela.com

Latest Breaking News On - Firas zahr - Page 5 : comparemela.com

FDA Approves Pascal Precision System for Mitral Regurgitation

Pivotal data will be released this weekend for the transcatheter valve system, which is already approved for the treatment of mitral and tricuspid regurgitation in Europe.

United statesFiras zahrEdwards lifesciencesScience universityDrug administrationOregon healthTranscatheter cardiovascular therapeutics

Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference

/PRNewswire/ Edwards Lifesciences Corporation (NYSE: EW) will discuss the company s strategy for longer-term growth, provide an update on its technology.

New yorkUnited statesNordrhein westfalenNorthwestern schoolPalo altoColumbia universityCity ofUnited kingdomPhilippe genereuxPhilipp lurzVolker rudolphChristopher youngMichaela mussallemScott ullemKevin accolaRahul sharma

Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference

/PRNewswire/ Edwards Lifesciences Corporation (NYSE: EW) will discuss the company s strategy for longer-term growth, provide an update on its technology.

New yorkUnited statesNordrhein westfalenNorthwestern schoolPalo altoColumbia universityCity ofUnited kingdomPhilippe genereuxPhilipp lurzVolker rudolphChristopher youngMichaela mussallemScott ullemKevin accolaRahul sharma

Good Results, But Small Numbers With JenaValve Trilogy in Severe AR

Treatments are limited for surgery-ineligible patients with severe AR, but this particular TAVI system is raising hopes.

United statesCity ofUnited kingdomAndrew goldsweigFiras zahrScience universityJenavalve technologyMd oregon healthDrug administrationMs university of nebraska medical centerMd university hospital cologne heart centerTechnology promisingMatti adamUniversity hospital cologne heart centerJenavalve trilogyEuropean society

Medtronic announces early data for the Intrepid™ transcatheter mitral valve replacement (TMVR) system using new transfemoral delivery system

/PRNewswire/ Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today presented early data for its self-expanding Intrepid™ transcatheter.

United statesFiras zahrRyan weispfenningJoey lomickyNina goodheartScience universityExchange commissionHeart valve program at oregon healthJournal of the american college cardiologyOur missionCardiovascular research foundationLate breaking clinical scienceTranscatheter cardiovascular therapeuticsEarly feasibility studyIntrepid transfemoral systemAmerican college

vimarsana © 2020. All Rights Reserved.